In contrast, RHOA and IDH2 mutations are restricted to neoplastic PD1-positive cells, suggesting a multi-step mutational hierarchy in AITL oncogenesis36,81 (Fig. 3). The gene discussed is RHOA; the disease is angioimmunoblastic T-cell lymphoma.